WallStreetZenWallStreetZen

NASDAQ: DRRX
Durect Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for DRRX

Based on 3 analysts offering 12 month price targets for Durect Corp.
Min Forecast
$32.00+456.04%
Avg Forecast
$37.67+554.51%
Max Forecast
$44.00+664.55%

Should I buy or sell DRRX stock?

Based on 3 analysts offering ratings for Durect Corp.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DRRX stock forecasts and price targets.

DRRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Top 3%
98
Strong BuyReiterates$44.00+664.55%2023-05-17
HC Wainwright & Co.
Top 11%
90
BuyReiterates$32.00+456.04%2023-05-09
JonesTrading
Bottom 16%
16
Strong BuyInitiates Coverage On$37.00+542.92%2023-03-14

1 of 1

Forecast return on equity

Is DRRX forecast to generate an efficient return?
Company
N/A
Industry
0.05%
Market
71.96%

Forecast return on assets

Is DRRX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.03%

DRRX revenue growth forecast

How is DRRX forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
135.92%
Industry
8.48%
Market
8.43%
DRRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DRRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DRRX vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
DRRX$5.76$37.67+554.51%Strong Buy
OPTN$1.21N/AN/A
XXII$0.61N/AN/A
PRPH$8.58$14.00+63.17%Buy
OGI$0.39N/AN/A
View Top Pharmaceutical Stocks

Durect Stock Forecast FAQ

Is Durect Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: DRRX) stock is to Strong Buy DRRX stock.

Out of 3 analysts, 2 (66.67%) are recommending DRRX as a Strong Buy, 1 (33.33%) are recommending DRRX as a Buy, 0 (0%) are recommending DRRX as a Hold, 0 (0%) are recommending DRRX as a Sell, and 0 (0%) are recommending DRRX as a Strong Sell.

If you're new to stock investing, here's how to buy Durect stock.

What is DRRX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: DRRX) forecast ROE is N/A, which is considered weak.

What is DRRX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year DRRX price target, the average DRRX price target is $37.67, with the highest DRRX stock price forecast at $44.00 and the lowest DRRX stock price forecast at $32.00.

On average, Wall Street analysts predict that Durect's share price could reach $37.67 by May 17, 2024. The average Durect stock price prediction forecasts a potential upside of 554.51% from the current DRRX share price of $5.76.

What is DRRX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: DRRX) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.03%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.